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F4 (K88) fimbriaeEnterotoxigenic Escherichia coli strains expressing F4 (K88) fimbriae (F4-ETEC) are one of the most impor-
tant causes of post-weaning diarrhea (PWD) in pigs. F4, a major antigen, plays an important role in the
early steps of the infection. Herein, the efficacy of a live oral vaccine consisting of a non-pathogenic E. coli
strain expressing F4 for protection of pigs against PWD was evaluated. Three blinded, placebo-controlled,
block design, parallel-group confirmatory experiments were conducted, using an F4-ETEC PWD challenge
model, each with a different vaccination-challenge interval (3, 7, and 21 days). The pigs were vaccinated
via the drinking water with a single dose of the Coliprotec F4 vaccine one day post-weaning. Efficacy
was assessed by evaluating diarrhea, clinical observations, intestinal fluid accumulation, weight gain,
intestinal colonization and fecal shedding of F4-ETEC. The immune response was evaluated by measuring
serum and intestinal F4-specific antibodies. The administration of the vaccine resulted in a significant
reduction of the incidence of moderate to severe diarrhea, ileal colonization by F4-ETEC, and fecal shed-
ding of F4-ETEC after the heterologous challenge at 7 and 21 days post-vaccination. The 7-day onset of
protection was associated with an increase of serum anti-F4 IgM whereas the 21-day duration of protec-
tion was associated with an increase of both serum anti-F4 IgM and IgA. Significant correlations between
levels of serum and intestinal secretory anti-F4 antibodies were detected. Maternally derived F4-specific
serum antibodies did not interfere with the vaccine efficacy. The evaluation of protection following a
challenge three days after vaccination showed a reduction of the severity and the duration of diarrhea
and of fecal shedding of F4-ETEC. The 7-day onset and the 21-day duration of protection induced by
Coliprotec F4 vaccine administered once in drinking water to pigs of at least 18 days of age were con-
firmed by protection against F4-ETEC and induction of F4-specific protective immunity.
 2016 The Authors. Published by Elsevier Ltd. This is an openaccess article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction
PWD1 in pigs is a worldwide economically important disease due
to mortality, weight loss, slow growth, treatment costs, and weight
heterogeneity [1–6]. Current control strategies usually involve the
use of antimicrobials; however, the emergence of antimicrobial
resistance among Escherichia coli isolates from cases of PWD high-
lights the need for alternative control measures [7–10].PWD typically occurs in the first weeks after weaning and is
characterized by a marked decrease in feed consumption and diar-
rhea. Pigs become rapidly dehydrated and depressed; and they
may die suddenly or after a short illness [11]. PWD is mainly
caused by ETEC2 that express F4 or F18 adhesive fimbriae, required
for the colonization of the intestinal mucosa, and enterotoxins that
induce secretory diarrhea [12–14]. Susceptibility of pigs to diarrhea
due to F4-ETEC has been linked to a polymorphism on the MUC4
gene [15,16].
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tion of pregnant sows [17,18]. However, passive lactogenic protec-
tion is rapidly lost after weaning and an active mucosal immunity
has to be elicited to protect pigs against PWD [19]. To this end, oral
vaccination of pigs represents a sustainable, practical, and effective
approach.
Here, we report results demonstrating the efficacy of Colipro-
tec F4, an oral vaccine for active immunization of pigs against
PWD caused by F4-ETEC. These studies were designed to demon-
strate the onset and duration of protective immunity using an
F4-ETEC PWD porcine challenge model.2. Materials and methods
2.1. Vaccine and challenge strains
Coliprotec F4 (Prevtec Microbia GmbH, Germany) is a single-
dose vaccine consisting of a live non-pathogenic E. coli O8:K87 (O
and K antigens) lyophilisate that was reconstituted and diluted in
water prior to its oral administration to pigs. The vaccine strain is
positive for F4 fimbriae (formerly K88) and negative for toxins.
The F4-ETEC EcL8559 O149 challenge strain (Prevtec Microbia
Inc., Canada) is nalidixic acid resistant, Beta-haemolytic, and posi-
tive for the enterotoxins STa, STb, LT and East-1 [20]. The challenge
strain was prepared from one frozen seed vial that was grown in
500 ml of tryptic soy broth (TSB) for 4 h at 37 C under 150 rpm
agitation. Optical density was measured, the fresh culture was
diluted with TSB and then administered.2.2. Animals
Studies were performed at the Université de Montréal (UdeM,
Canada) after being approved by the university animal care and
ethics committee following the Canadian Council on Animal Care
guidelines. A total of 80 castrated male and female pigs born to
crossbred sows (Yorkshire-Landrace  Pen Ar Lan Naïma) were
obtained from a conventional pig farm. All gilts of the herd were
vaccinated against ETEC causing neonatal diarrhea prior to farrow-
ing. Piglets were weaned at 17 or 18 days of age. Before weaning,
susceptibility of piglets to F4-ETEC infection was investigated by
analyzing the MUC4 polymorphism [21]. Only susceptible pigs
were selected and are referred to as F4R+ pigs. Animals had ad libi-
tum access to water and to non-medicated feed.2.3. Experimental design
Three blinded, placebo-controlled, block design, parallel-group
confirmatory experiments were conducted using an F4-ETEC
PWD challenge model, each with a different vaccination-
challenge interval set at 3, 7, and 21 days, respectively (Table 1).
Pigs were distributed between vaccine or control groups followingTable 1
Design of the Coliprotec F4 vaccine efficacy experiments. Vaccine and challenge doses
performed using the F4-ETEC EcL8559 strain.
Experiment Group Number of
animals
Treatment (lot number) Vac
7-dpv challenge Vaccine 10 Coliprotec F4 (121811) 1.3 
Control 10 Water Not
21-dpv challenge Vaccine 10 Coliprotec F4 (121811) 1.3 
Control 10 Water Not
3-dpv challenge Vaccine 20 Coliprotec F4 (122964) 5.9 
Control 20 Water Nota randomized complete block design within litters (1:1 ratio) with
the generation of block size n = 4.
Experiments with challenge at 7 and 21 days post-vaccination
(dpv) were done concurrently. Forty F4R+ pigs from 8 litters were
transferred into the experimental units at weaning. The vaccinated
pigs of both experiments (10 pigs each) were commingled in a sin-
gle experimental unit and the unvaccinated pigs (controls) of both
experiments (10 pigs each) were commingled in another experi-
mental unit until their respective challenge phase. The vaccine
was administrated via the drinking water using 150 ml per pig in
a snap-in nursery feeder bowl. Control animals received 150 ml
of filtered water per pig. The vaccine/control was consumed within
4 h. At 7 or 21 dpv, 10 vaccinates and 10 controls were transferred
into a challenge room. The challenge strain was administered to
each pig using an oesophageal tube after the administration of
10 ml of a 1.2% carbonate solution. Pigs were monitored for 3 days
post-challenge (dpc) and then euthanized. Necropsy was per-
formed on each animal.
Another similar experiment involved an early challenge per-
formed at 3 dpv. Forty F4R+ piglets from 10 litters were transferred
at weaning into the experimental units. Treatments were adminis-
tered as previously described. Pigs were transferred at 3 dpv into a
challenge room, challenged as previously described and monitored
for 5 days before being euthanized. No necropsy was done.2.4. Clinical and pathological examination
Animals were monitored once daily before and twice daily after
the challenge for general health, behavior, appetite, body condi-
tion, and hair coat. Fecal consistency score and dehydration were
evaluated once per day throughout the experiments. The fecal con-
sistency was evaluated on a continuous scale with 5 levels: (0) nor-
mal, (1) pasty, (2) presence of liquid but more solid particles than
liquid, (3) presence of more liquid than solid particles, and (4)
totally liquid. Fecal consistency scores of 2, 3 and 4 were consid-
ered as mild, moderate and severe diarrhea, respectively. In the
early challenge experiment, the severity and the duration of diar-
rhea were assessed as the post-challenge period was longer. The
severity of diarrhea is the mean of the fecal consistency scores
for each dpc. Duration of diarrhea is the number of days from the
first to the last day showing diarrhea. For all challenge experi-
ments, pigs were weighed on arrival at the facility, on the chal-
lenge day and at the study completion. For the 21-dpv challenge
experiment, pigs were also weighed at 7 and 14 dpv.
Gross pathological findings were evaluated at necropsy for the
7-dpv and the 21-dpv challenge experiments. The consistency of
the contents from the jejunum, ileum, caecum, colon and rectum
was scored on an ordinal scale with 4 levels: (0) normal, (1) pasty,
(2) presence of liquid but more solid particles than liquid, (3) pres-
ence of more liquid than solid particles or totally liquid. An intesti-
nal segment with a consistency score >1 was considered having
fluid accumulation and pigs presenting 2 or more intestinalare reported as Colony Forming Unit (CFU) administered per pig. Challenges were
cine dose
(CFU)
Vaccination-challenge
interval (days)
Challenge
dose (CFU)
Challenge-euthanasia
interval (days)
108 7 1.5  109 3
applicable 7 1.5  109 3
108 21 9.5  108 3
applicable 21 9.5  108 3
107 3 1.7  109 5
applicable 3 1.7  109 5
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hypersecretion.
2.5. Bacteriological examination
Fecal shedding of the challenge strain was quantified using a
standard live bacterial count method. Fresh fecal samples were col-
lected daily from the day of the challenge to the study completion
using pre-weighed sterile rectal swabs and transportation tubes.
After weighing fecal samples, phosphate-buffered saline 0.1 M,
pH 7.4 (PBS) was used to suspend feces and for ten-fold serial dilu-
tions. Counting of typical colonies on tryptic soy agar with 5%
sheep blood and 5 mg/L nalidixic acid was done after an overnight
incubation at 37 C. To evaluate ileum colonization by the chal-
lenge strain, approximately 2 cm of the ileum was sampled at
about 10 cm from the ileocecal valve. A piece of ileumwas weighed
(between 0.1 g and 0.2 g) and was suspended in 1 ml of PBS,
ground with a homogenizer and used for the bacterial count as
described for fecal shedding. CFU/g of fecal or ileum sample result
was calculated using the CFU/ml and weight of the sample.
2.6. Antibody analyses
Sera were prepared with blood collected from the cranial vena
cava on the respective experiment days of vaccination, challenge
and completion of the study for the 7-dpv and 21-dpv challenge
experiments only. Serum samples were stored at 75 ± 5 C until
analysis. Levels of serum anti-F4 IgM, IgA and IgG were quantified
using indirect ELISA as previously described [22] with the follow-
ing modifications. Microlon microplates (Greiner Bio-One, Ger-
many) were coated with 2.5 lg/ml F4 fimbriae. The blocking
solution was prepared with 1% bovine serum albumin and 0.2%
Tween 80. Serum samples were diluted 1:10, 1:20 and 1:1200
and the HRP conjugated secondary antibodies 1:15,000, 1:3000
and 1:20,000 for anti-F4 IgM, IgA or IgG, respectively. The ABTS
single reagent (EMD Millipore, USA) was incubated for one hour
at room temperature before reading optical densities at 405 nm.
Three replicates for each serum sample were analyzed and each
microplate contained samples of a strong positive, a weak positive
and a negative control (Prevtec Microbia Inc., Canada). Antibody
levels were reported as percent positivity (PP) of the respective
strong positive control [23].
To determine intestinal anti-F4 IgM and IgA, 10–20 ml of the
jejunum and ileum contents were collected at necropsy, prepared
[24], frozen at 75 ± 5 C, concentrated 5-times by freeze drying
and rehydrated with sterile water. Intestinal antibodies were
quantified using the same ELISA method used for the respective
serum antibody, except that the optical density of the strongTable 2
Incidence of pigs (percentage) with diarrhea or with fluid accumulation for the 7-days post-
difference (p 6 0.05).
7-dpv challenge experiment
Vaccine (n = 9) Control (n = 10) p-valu
Diarrhea for each day post-challenge
0 0 0 –
1 11 10 0.808
2 11 20 0.808
3 0 40 0.041
Fluid accumulation in each intestinal segment
Jejunum 11 30 0.098
Ileum 12 78 0.003
Caecum 22 70 0.003
Colon 11 70 0.001
Rectum 0 40 0.002positive serum control was divided by 5 before calculating PP
results. Since antibodies in the contents are not confined to their
secretion site due to intestinal transit, group comparative analyses
were performed using the highest PP result among the intestinal
segments of each animal (hereafter ‘‘pig’s highest intestinal level”)
in addition to the PP of the jejunum and of the ileum.2.7. Statistical analysis
Reduction of diarrhea and intestinal hypersecretion were eval-
uated with the Cochran-Mantel-Haenszel test [25] with litter and
pen respectively as the stratification variable, using the mghr func-
tion from the Hmisc package [26] of R [27]. Intestinal segment fluid
accumulation was evaluated using Friedman’s test with litter as
the stratification variable. Reduction of fecal shedding and ileum
colonization by the challenge strain, and weight loss were evalu-
ated by ANOVA for block design. Serum antibody levels, their evo-
lution over time and intestinal antibody levels were also evaluated
with an ANOVA for block design. Correlation between the highest
intestinal antibody and serum antibody levels were performed
using Pearson’s correlation coefficient. All analyses were per-
formed with R statistical software [27] using a statistical signifi-
cance of 0.05.3. Results and discussion
3.1. Diarrhea, intestinal fluid accumulation and hypersecretion
A total of 5 vaccinates and 3 controls of the 7-dpv challenge
experiment and 4 vaccinates and 3 controls of the 21-dpv chal-
lenge experiment presented mild diarrhea (score 2) before the
challenge. Therefore, only scores of 3 (moderate) and 4 (severe)
were classified as post-challenge diarrhea for all experiments.
Moderate to severe diarrhea is hereafter referred to as diarrhea
for brevity. The incidence of pigs showing diarrhea at least once
after the 7-dpv challenge was 11% (1/9) for vaccinates and 40%
(4/10) for controls, with a statistically significant difference on
the third dpc at the peak of diarrhea (Table 2). Similar results were
observed after the 21-dpv challenge, with a significant reduction of
vaccinated pigs showing diarrhea at least once after challenge (0%
vaccinates vs 33% controls, p = 0.05). After the early 3-dpv chal-
lenge, 47% vaccinates and 74% controls had diarrhea at least once.
Even though this difference is not statistically significant
(p = 0.104), control pigs were affected more severely and Colipro-
tec F4 partially protected the pigs, which was demonstrated by
a significant reduction, at the peak of diarrhea (2 dpc), of the inci-
dence of diarrheic pigs and the severity of diarrhea (Table 3). Thevaccination (dpv) and 21-dpv challenge experiments. An asterisk denotes a significant
21-dpv challenge experiment
e Vaccine (n = 10) Control (n = 9) p-value
0 0 –
0 33 0.050⁄
0 11 0.317
⁄ 0 0 –
20 11 0.399
⁄ 22 38 0.281
⁄ 20 33 0.251
⁄ 0 11 0.080
⁄ 0 0 0.827
Table 3
Incidence of pigs (percentage) with diarrhea and severity of diarrhea (mean of scores) for the 3-day post-vaccination challenge experiment. An asterisk denotes a significant
difference (p 6 0.05).
Day post-challenge Incidence Severity
Vaccine (n = 20) Control (n = 20) p-value Vaccine (n = 20) Control (n = 20) p-value
0 5 0 – 0.4 0.2 0.458
1 20 25 0.691 0.9 1.3 0.412
2 25 63 0.026⁄ 1.2 2.4 0.023⁄
3 20 42 0.118 1.1 1.9 0.076
4 15 26 0.362 1.1 1.6 0.302
5 0 11 0.157 0.5 1.1 0.087
Fig. 1. Fecal shedding levels of the challenge strain for the 3 days post-challenge (dpc) and colonization levels of the ileum by the challenge strain at necropsy (day 3 post-
challenge) for the 7-day post-vaccination (dpv) challenge experiment (A) and the 21-dpv challenge experiment (B). Fecal shedding levels of the challenge strain for the 5 dpc
during the 3-dpv challenge experiment (C). Horizontal lines represent the geometric mean of CFU per gram of fecal material or ileum tissue. Open circles represent animals of
the control group; solid circles represent animals of the vaccinated group. An asterisk denotes a significant difference (p 6 0.05) between vaccinated and control pigs.
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J.M. Fairbrother et al. / Vaccine 35 (2017) 353–360 357duration of diarrhea was also significantly lower (p = 0.04) for vac-
cinates (1.4 day) than controls (2.4 days) after the 3-dpv challenge.
The incidence of pigs showing intestinal hypersecretion after
the 7-dpv challenge was significantly lower (p = 0.009) for vacci-
nates (11%) than for controls (70%), which was reflected by a signif-
icant reduction of pigs showing fluid accumulation in the ileum,
caecum, colon and rectum lumen (Table 2). However, the incidence
of pigs with intestinal hypersecretion was low at necropsy after the
21-dpv challenge for both treatment groups, without significant
difference for fluid accumulation in each intestinal segment
(Table 2).
Diarrhea caused by F4-ETEC is a result of multiple factors and is
clinically observed when the amount of fluid in the small intestines
exceeds the intestinal absorption capacity [28]. Though 70% of con-
trols showed fluid accumulation in the ileum, the caecum and the
colon after the 7-dpv challenge, only 40% did so in the rectum, in
accordance with the incidence of diarrheic pigs on the necropsy
day. In contrast, only one vaccinate showed hypersecretion and
another one had diarrhea. Contrary to results after the 7-dpv chal-
lenge, control pigs developed diarrhea the first day after the 21-
dpv challenge and recovered rapidly, resulting in 22% of controls
with hypersecretion at necropsy.
It was previously suggested that susceptibility to F4-ETEC diar-
rhea decreases with age of pigs or with the increase of the
weaning-challenge interval [29,30]. Results from the current three
studies are consistent with this hypothesis as 74%, 40% and 33% of
the  21-day-old (3 dpv),  25-day-old (7 dpv) and  39-day-old
(21 dpv) control pigs had diarrhea after the challenge, respectively.3.2. Fecal shedding and colonization of the ileum
In accordance with the clinical protection, Coliprotec F4 signif-
icantly reduced the fecal shedding of F4-ETEC as early as the first
day following the 7-dpv and 21-dpv challenges (Fig. 1A and B).
The fecal shedding of F4-ETEC was significantly reduced by vacci-
nation for the 3 days following the 7-dpv challenge (p = 0.044,
0.004 and 0.004, respectively) and the 21-dpv challenge
(p = 0.002, p < 0.001, and p < 0.001, respectively) experiments
(Fig. 1). These reductions reached 2.0log10 and 3.7log10 on the
third day following the 7-dpv and 21-dpv challenges, respectively.
However, following the 3-dpv challenge, the shedding was signifi-
cantly reduced by vaccination only for the last day (5 dpc) of the
study (1.0log10; p = 0.004) (Fig. 1C).
The ileal colonization by the challenge strain was also signifi-
cantly reduced for vaccinates compared to the controls followingTable 4
Bodyweight of pigs at the day before vaccination (day -1) and at the end of the respective e
the entire study period and the post-challenge period for the 3-dpv, 7-dpv and 21-dpv chall
Bodyweight (kg)
day -1 end of the study
7-dpv challenge experiment
Vaccine 6.330 8.545
Control 6.323 8.028
Difference +0.007 +0.517
p-value 0.990 0.517
21-dpv challenge experiment
Vaccine 5.845 15.551
Control 5.797 14.434
Difference +0.048 +1.117
p-value 0.923 0.280
3-dpv challenge experiment
Vaccine 5.458 5.769
Control 5.884 5.687
Difference 0.426 +0.082
p-value 0.027⁄ 0.739the 7-dpv challenge (p = 0.001) and the 21-dpv challenge
(p < 0.001) (Fig. 1), reaching a difference of 2.1log10 and 2.8log10
respectively.
3.3. Weight gain
Reduction in weight gain is part of the economic losses caused
by PWD, and delayed growth, which usually follows diarrheal epi-
sodes, makes the losses even worse [28]. Vaccinates challenged at
7 and 21 dpv showed a post-challenge DWG of 140 g and 175 g
higher than for controls, respectively (Table 4). Even though the
differences of DWG after the challenge are not statistically signifi-
cant, they are relevant since 40% and 11% of the controls chal-
lenged at 7 and 21 dpv, respectively, lost weight whereas no
vaccinate did. These differences in DWG resulted in vaccinates
heavier than controls by 517 g and 1117 g at the end of the 7-
dpv and 21-dpv challenge experiments, respectively (Table 4).
The DWG during the post-challenge period of the 3-dpv chal-
lenge experiment was significantly higher for vaccinates (29 g)
than for controls (53 g) (Table 4). The Coliprotec F4 partial clin-
ical protection observed after the 3-dpv challenge experiment
resulted in an average weight gain for the entire study period of
311 g for vaccinates compared to an average weight loss of 197 g
for the controls.
3.4. Antibody responses
Antibody responses to the F4 antigen were analyzed for the 7
and 21 dpv challenge experiments. Serum levels of anti-F4 IgM
and IgA were low at vaccination. Statistically significant differences
in evolution over time of serum anti-F4 IgM (p < 0.001 for both
experiments) and IgA (p = 0.025 and p = 0.001 for 7 and 21 dpv
challenge experiments, respectively) were observed between vac-
cinates and controls (Fig. 2). Significantly higher levels of serum
antibodies were detected for vaccinates compared to controls dur-
ing the 7-dpv challenge experiment at 7 dpv (IgM, p = 0.05) and
10 dpv (IgM, p < 0.001; IgA, p = 0.04). Vaccinates of the 21-dpv
challenge experiment showed significantly higher serum anti-F4
IgM and IgA than controls from 10 dpv onward (IgM, p-
values < 0.001, <0.001, 0.02 and 0.03; IgA, p = 0.02, 0.01, 0.007,
0.002, respectively at 10, 14, 21 and 24 dpv).
Marginally significant higher levels of anti-F4 IgM (p = 0.061)
and IgA (p = 0.093) were detected in the jejunum of vaccinates
necropsied at 10 dpv (Fig. 2A). Vaccinated pigs necropsied at
24 dpv showed significantly higher levels of anti-F4 IgM and IgAxperiment (8, 10 or 24 days post-vaccination [dpv]) and daily weight gain (DWG) for
enge experiments, respectively. An asterisk denotes a significant difference (p 6 0.05).
DWG (g)
entire study period post-challenge period
188 293
155 153
+33 +140
0.321 0.153
388 541
339 366
+49 +175
0.056 0.071
30 29
16 53
+46 +82
0.019⁄ 0.007⁄
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tively) (Fig. 2B). When the pig’s highest intestinal level was consid-
ered, anti-F4 IgA were significantly higher for vaccinates than
controls at 10 dpv (7-dpv challenge experiment; p = 0.025) or mar-
ginally higher at 24 dpv (21-dpv challenge experiment; p = 0.067).0 7 10
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anti-F4 IgM from 7 dpv that peaked around 14 dpv and anti-F4
IgA from 10 dpv that were maintained until 24 dpv (study comple-
tion of the 21-dpv challenge experiment). Results showed a signif-
icant correlation between the serum and the pig’s highest
intestinal antibody levels for anti-F4 IgM (p = 0.016) and IgA
(p = 0.002) at 10 dpv, as well as for IgA (p < 0.001) at 24 dpv.
IgM is important as a secreted mucosal isotype in young pigs
[34]. Though the shift from IgM to IgA as the predominant porcine
intestinal isotype was reported to occur at about 12 weeks of age
[35], a more rapid switch was observed with Coliprotec F4. Ver-
donck et al. [24] demonstrated induction of mucosal and systemic
F4-specific antibodies as early as 4 days after oral inoculation with
a live F4-ETEC, which is 3 days earlier than the 7 dpv timepoint
monitored in our experiments. No blood sampling of pigs was car-
ried out in the 3-dpv challenge experiment and the contribution of
an early production of anti-F4 antibodies in the observed partial
protection is unknown. Competitive exclusion of F4-ETEC by the
vaccine strain, reducing their intestinal colonization, is plausible
shortly after vaccination, as the vaccine strain was detected at
3 dpv by PCR in fecal samples of 17 of the 20 vaccinated pigs (data
not shown). However, fecal shedding of the F4-ETEC challenge
strain was significantly reduced by vaccination only on the fifth
day following the 3-dpv challenge, thus at 8 dpv. This timepoint
is in accordance with the 7-day onset of immunity and protection
demonstrated when pigs were challenged at 7 dpv. Competitive
exclusion would not be an important mechanism of protection
later on as only 3 out of 9 and 0 out of 10 vaccinated pigs were pos-
itive for the vaccine strain at 7 dpv and 21 dpv, respectively.
As expected, high levels of serum anti-F4 IgG were detected in
both vaccinates and controls before the vaccination (data not
shown) since pigs originated from a farm where gilts were immu-
nized using a vaccine containing the F4 antigen. No interference of
these maternally derived antibodies with the Coliprotec F4 effi-
cacy was observed. It was recently demonstrated that serum
anti-F4 maternal antibodies enhance the secondary systemic
immune response after oral immunization of pigs with F4 fimbriae
[36].3.5. Mortality and adverse event
One vaccinate of the 7-dpv challenge experiment was eutha-
nized on the vaccination day due to severe lameness of the right
hind limb that started the day before the vaccination after handling
the animal. One control animal of the 21-dpv challenge experiment
was euthanized at day 8 due to lateral decubitus and severe dysp-
nea. The pathology confirmed purulent rhinitis and severe bron-
chopneumonia caused by a complex of Bordetella bronchiseptica,
Pasteurella multocida and Streptococcus suis. During the 3-dpv chal-
lenge experiment, one control pig was euthanized on the second
dpc due to severe PWD caused by the challenge strain and one vac-
cinated animal was euthanized on the fourth dpc. The diagnostic
testing showed a mixed infection of chronic interstitial pneumonia,
suppurative bronchopneumonia due to S. suis and B. bronchiseptica,
non-pandemic H1N1 porcine influenza and PWD caused by the
challenge strain. All euthanasia were done for animal welfare rea-
sons and all the events are considered not to be related to
vaccination.4. Conclusion
The present studies evaluated the efficacy of a live oral E. coli
single-dose vaccine (Coliprotec F4) to protect pigs against a F4-
ETEC oral challenge at 3, 7 or 21 dpv and monitored specific
immune responses. Results demonstrated that in pigs of at least18 days of age, the administration of a single dose of Coliprotec F4
via drinking water induces clinical protection against F4-ETEC
within 7 days of vaccination and that protection is maintained
until 21 days post-vaccination. The protection was demonstrated
by a significant reduction of pigs having moderate to severe
post-weaning diarrhea, ileum colonization by F4-ETEC and fecal
shedding of F4-ETEC in infected pigs. A partial protection was
observed after an early challenge at 3 dpv.
The 7-day onset of clinical protection was associated with an
increase of anti-F4 IgM. Anti-F4 IgA induced from 10 dpv, along
with anti-F4 IgM, were associated with the 21-day duration of pro-
tection. Significant correlations between serum and intestinal
secretory anti-F4 antibodies were shown at 10 and 24 dpv.
Finally, it is worth noting that, though not statistically signifi-
cant, vaccinated pigs were heavier than control pigs at the end of
all studies.
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